Stories Library

We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.

June 26, 2023

Biomarkers Go Digital

By: Bari Kowal, Senior Vice President, Head of Development Operations & Portfolio Management 

Biomarkers Go Digital

Clinical Research & Medicines

May 23, 2023

Changing the Paradigm in COPD: Rethinking the Science & Removing Barriers

By: Bola Akinlade, MD, MBA, FACP,
Senior Vice President, Therapeutic Area Head, Immunology & Inflammation

Committed to a patient-centered and science-forward approach

Clinical Research & Medicines

May 23, 2023

An Unequivocal Victory for Innovation

By: Len Schleifer, MD, PhD, President and Chief Executive Officer

A recent Supreme Court decision helps patients by protecting the scientific innovation emerging from America’s thriving biopharma community

Responsibility & Culture

May 03, 2023

Responsible Innovation: Taking a Holistic Approach to Our Mission to Improve Lives

By: Linnea Texin, Senior Director, Corporate Responsibility

Unlocking the power of our business to “Do Well by Doing Good”

Responsibility & Culture

Diagram showing a therapeutic agent, VEGF molecule and two VEGF receptors.

April 17, 2023

Our Impact on Diseases of the Retina: Always Striving for Innovation

By: Kimberly Reed, Global Medical Affairs, Regeneron Ophthalmology

Regeneron’s unique impact on ophthalmology

Clinical Research & Medicines

January 25, 2023

Más genómica, menos miedo

By: Adolfo Ferrando, MD, PhD, Executive Director, Therapeutic Area Genetics, Oncology, Regeneron Genetics Center

El genoma es el cómo y el por qué que nos define

Genetics, Research & Preclinical Development

January 25, 2023

More Genomics, Less Fear

By: Adolfo Ferrando, MD, PhD, Executive Director, Therapeutic Area Genetics, Oncology, Regeneron Genetics Center

The genome is the how and why that define us

Genetics, Research & Preclinical Development

Graphic reading '1 in 700 PEOPLE have the rare loss-of-function CIDEB genetic mutation.'

October 03, 2022

Going “all in” with liver disease genetics

By: Luca A. Lotta, MD, PhD, Vice President, Head of Cardiometabolic and Musculoskeletal Disease Genetics

The "Team Science" approach leading to the discovery of CIDEB mutations that protect from liver disease

Genetics

August 01, 2022

Experience Our Spectacular Science

At Regeneron, we continue to stay on the cutting edge as we build the medicines of tomorrow.

Technology

July 29, 2022

Defining Internship Experiences

By: Regina Thomas, Executive Director, Talent Acquisition

Nurturing the Next Generation of Scientific Innovators

Responsibility & Culture